Sarepta Therapeutics Inc SRPT:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
85.50quote price arrow down-0.88 (-1.02%)
Volume
453,253
Close
86.38quote price arrow up+0.75 (+0.88%)
Volume
1,476,784
52 week range
65.30 - 181.83
Loading...
  • Open85.43
  • Day High86.77
  • Day Low83.38
  • Prev Close85.63
  • 52 Week High181.83
  • 52 Week High Date12/22/20
  • 52 Week Low65.30
  • 52 Week Low Date07/27/21

Key Stats

  • Market Cap6.897B
  • Shares Out79.84M
  • 10 Day Average Volume0.66M
  • Dividend-
  • Dividend Yield-
  • Beta1.53
  • YTD % Change-49.33

KEY STATS

  • Open85.43
  • Day High86.77
  • Day Low83.38
  • Prev Close85.63
  • 52 Week High181.83
  • 52 Week High Date12/22/20
  • 52 Week Low65.30
  • 52 Week Low Date07/27/21
  • Market Cap6.897B
  • Shares Out79.84M
  • 10 Day Average Volume0.66M
  • Dividend-
  • Dividend Yield-
  • Beta1.53
  • YTD % Change-49.33

RATIOS/PROFITABILITY

  • EPS (TTM)-8.03
  • P/E (TTM)-10.76
  • Fwd P/E (NTM)-11.82
  • EBITDA (MRQ)-585.939M
  • ROE (MRQ)-83.05%
  • Revenue (MRQ)600.08M
  • Gross Margin (MRQ)86.79%
  • Net Margin (MRQ)-105.73%
  • Debt To Equity (MRQ)225.31%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sarepta Therapeutics Inc

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of rare neuromuscular diseases. It operates through discovering, developing, manufacturing and delivering therapies to patients with Duchenne muscular dystrophy (DMD). It is focused on the development of its disease-modifying DMD drug candidates. It has received accelerated approval for its...
M. Kathleen Behrens Ph.D.
Non-Executive Chairman
Douglas Ingram Esq., J.D.
President
Ian Estepan
Chief Financial Officer
Louise Rodino-Klapac Ph.D.
Executive Vice President
William Ciambrone
Executive Vice President
Address
215 1st St Ste 415
Cambridge, MA
02142-1213
United States

Top Peers

SYMBOLLASTCHG%CHG
NVTA
Invitae Corp
31.54+1.80+6.05%
HALO
Halozyme Therapeutics Inc
42.04-0.01-0.02%
DNLI
Denali Therapeutics Inc
52.83-0.20-0.38%
GLPG
Galapagos NV
55.64+0.35+0.63%
RARE
Ultragenyx Pharmaceutical Inc
98.27+2.04+2.12%